Becton Dickinson Goodwill and Intangible Assets 2010-2024 | BDX
Becton Dickinson goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- Becton Dickinson goodwill and intangible assets for the quarter ending September 30, 2024 were $34.456B, a 4.01% decline year-over-year.
- Becton Dickinson goodwill and intangible assets for 2023 were $35.47B, a 3.96% decline from 2022.
- Becton Dickinson goodwill and intangible assets for 2022 were $36.931B, a 0.74% increase from 2021.
- Becton Dickinson goodwill and intangible assets for 2021 were $36.659B, a 2.07% decline from 2020.
Becton Dickinson Annual Goodwill and Intangible Assets
(Millions of US $) |
| 2023 |
$35,470 |
| 2022 |
$36,931 |
| 2021 |
$36,659 |
| 2020 |
$37,433 |
| 2019 |
$38,354 |
| 2018 |
$40,041 |
| 2017 |
$13,456 |
| 2016 |
$13,700 |
| 2015 |
$14,561 |
| 2014 |
$1,850 |
| 2013 |
$1,943 |
| 2012 |
$1,889 |
| 2011 |
$1,790 |
| 2010 |
$1,303 |
| 2009 |
$1,029 |
Becton Dickinson Quarterly Goodwill and Intangible Assets
(Millions of US $) |
| 2024-06-30 |
$34,456 |
| 2024-03-31 |
$34,826 |
| 2023-12-31 |
$35,211 |
| 2023-09-30 |
$35,470 |
| 2023-06-30 |
$35,897 |
| 2023-03-31 |
$36,457 |
| 2022-12-31 |
$36,753 |
| 2022-09-30 |
$36,931 |
| 2022-06-30 |
$35,855 |
| 2022-03-31 |
$36,363 |
| 2021-12-31 |
$36,727 |
| 2021-09-30 |
$36,659 |
| 2021-06-30 |
$36,811 |
| 2021-03-31 |
$37,020 |
| 2020-12-31 |
$37,315 |
| 2020-09-30 |
$37,433 |
| 2020-06-30 |
$37,658 |
| 2020-03-31 |
$37,788 |
| 2019-12-31 |
$38,160 |
| 2019-09-30 |
$38,354 |
| 2019-06-30 |
$38,839 |
| 2019-03-31 |
$39,220 |
| 2018-12-31 |
$39,567 |
| 2018-09-30 |
$40,041 |
| 2018-06-30 |
$40,147 |
| 2018-03-31 |
$40,491 |
| 2017-12-31 |
$41,375 |
| 2017-09-30 |
$13,456 |
| 2017-06-30 |
$13,501 |
| 2017-03-31 |
$13,446 |
| 2016-12-31 |
$13,492 |
| 2016-09-30 |
$13,700 |
| 2016-06-30 |
$13,831 |
| 2016-03-31 |
$13,979 |
| 2015-12-31 |
$14,239 |
| 2015-09-30 |
$14,561 |
| 2015-06-30 |
$14,588 |
| 2015-03-31 |
$15,220 |
| 2014-12-31 |
$1,960 |
| 2014-09-30 |
$1,850 |
| 2014-06-30 |
$1,911 |
| 2014-03-31 |
$1,945 |
| 2013-12-31 |
$1,914 |
| 2013-09-30 |
$1,943 |
| 2013-06-30 |
$1,933 |
| 2013-03-31 |
$1,964 |
| 2012-12-31 |
$1,971 |
| 2012-09-30 |
$1,889 |
| 2012-06-30 |
$1,784 |
| 2012-03-31 |
$1,837 |
| 2011-12-31 |
$1,780 |
| 2011-09-30 |
$1,790 |
| 2011-06-30 |
$1,541 |
| 2011-03-31 |
$1,551 |
| 2010-12-31 |
$1,294 |
| 2010-09-30 |
$1,303 |
| 2010-06-30 |
$1,293 |
| 2010-03-31 |
$1,327 |
| 2009-12-31 |
$1,338 |
| 2009-09-30 |
$1,029 |
| 2009-06-30 |
$1,015 |
| 2009-03-31 |
$1,009 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.746B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
